Earningsreport

Q2/2017 6/30/2017 EPS -0.080 ZacksConsensus N/A ActVsEst N/A - N/A

HEMISPHERX BIOPHARMA  (HEB) 
NASDAQ:AMEX Investor Relations: hemispherx.net/mobile/investor-relations.php